Drug application
POSACONAZOLE (POSACONAZOLE)
Drugs@FDA ANDA 219057 · ASPIRO
Key facts
| Drug name | POSACONAZOLE |
|---|---|
| Active ingredients | POSACONAZOLE |
| Application type | ANDA |
| Application number | 219057 |
| Company | ASPIRO |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 300MG/16.7ML (18MG/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Dec 23, 2024 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.